Treatment Resistance with Covalent BTKis: Translating Data into Clinical Practice
Javier Pinilla, MD, PhD explores evidence on molecular mechanisms leading to resistance in second-generation BTK inhibitors for CLL, providing insights from recently presented data at ASH 2023.
Javier Pinilla Exploring Therapeutic Advancements Chronic Lymphocytic Leukemia Translating Data Covalent Btkis Covalent Btk Inhibitors
Source: onclive.com